tiprankstipranks
Trending News
More News >
Emmaus Life Sciences Inc (EMMA)
OTHER OTC:EMMA
US Market

Emmaus Life Sciences (EMMA) Income Statement

Compare
89 Followers

Emmaus Life Sciences Income Statement

Last quarter (Q3 2024), Emmaus Life Sciences's total revenue was $5.48M, an increase of 9.17% from the same quarter last year. In Q3, Emmaus Life Sciences's net income was $1.83M. See Emmaus Life Sciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 16.65M$ 29.60M$ 18.39M$ 20.61M$ 23.17M
Gross Profit
$ 15.45M$ 28.25M$ 15.80M$ 17.30M$ 20.92M
Operating Expenses
$ 17.35M$ 24.71M$ 22.39M$ 23.43M$ 20.95M
Depreciation and Amortization
$ 10.02M$ 32.00K$ 53.00K$ 59.00K$ 60.00K
EBITDA
$ -1.89M$ 3.57M$ -5.50M$ -12.76M$ 28.00K
Operating Income
$ -1.89M$ 3.54M$ -6.59M$ -6.13M$ -43.00K
Other Income/Expenses
$ -4.53M$ -7.33M$ -3.98M$ -9.79M$ 1.00M
Pretax Income
$ -6.42M$ -3.79M$ -10.63M$ -15.92M$ 719.00K
Net Income
$ -6.45M$ -3.73M$ -10.69M$ -15.95M$ 1.35M
Per Share Metrics
Basic EPS
$ -0.10$ -0.07$ -0.22$ -0.32$ 0.03
Diluted EPS
$ -0.10$ -0.07$ -0.22$ -0.32$ 0.03
Weighted Average Shares Outstanding
63.23M 53.11M 49.44M 49.25M 48.90M
Weighted Average Shares Outstanding (Diluted)
63.23M 53.11M 49.44M 49.25M 48.90M
Currency in USD

Emmaus Life Sciences Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis